Efficacy of insulin degludec in young persons with Type 1 diabetes after switching from insulin glargine or insulin detemir HL Tan and

被引：0
|
作者：
Tan, H. L. [1 ]
Chau, F. [1 ]
机构：
[1] North Bristol NHS Trust, Bristol, Avon, England
来源：
DIABETIC MEDICINE | 2016年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P246
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [41] Relationship of Insulin Dose, A1c Lowering, and Weight in Type 2 Diabetes: Comparing Insulin Glargine and Insulin Detemir
    Dailey, George
    Admane, Karim
    Mercier, Florence
    Owens, David
    DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (12) : 1019 - 1027
  • [42] Cost analysis of insulin degludec in comparison with insulin detemir in treatment of children and adolescents with type 1 diabetes in the UK
    Thalange, Nandu
    Gundgaard, Jens
    Parekh, Witesh
    Tutkunkardas, Deniz
    BMJ OPEN DIABETES RESEARCH & CARE, 2019, 7 (01)
  • [43] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in subjects with type 1 diabetes
    Heise, T
    Nosek, L
    Draeger, E
    Stender, A
    Ronn, BB
    Kapitza, C
    Heinemann, L
    DIABETES, 2003, 52 : A121 - A121
  • [44] Insulin Analogues Insulin Glargine and Insulin Glulisine in Type 1 Diabetes
    Schreiber, S. A.
    Fiesselmann, A.
    Bornstein, S. R.
    Landgraf, W.
    DIABETES STOFFWECHSEL UND HERZ, 2011, 20 (02): : 69 - 77
  • [45] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes
    Heise, T
    Nosek, L
    Ronn, BB
    Endahl, L
    Heinemann, L
    Kapitza, C
    Draeger, E
    DIABETES, 2004, 53 (06) : 1614 - 1620
  • [46] Comparison of insulin degludec with insulin detemir in type 1 diabetes: a 1-year treat-to-target trial
    Davies, M.
    Sasaki, T.
    Gross, J. L.
    Bantwal, G.
    Ono, Y.
    Nishida, T.
    Tojjar, D.
    Seino, H.
    DIABETES OBESITY & METABOLISM, 2016, 18 (01): : 96 - 99
  • [47] Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials
    Zhang, Xiao-Wen
    Zhang, Xin-Lin
    Xu, Biao
    Kang, Li-Na
    ACTA DIABETOLOGICA, 2018, 55 (05) : 429 - 441
  • [48] Switching from insulin glargine to insulin degludec reduced HbA1c, daily insulin doses and anti-insulin antibody in anti-insulin antibody-positive subjects with type 1 diabetes
    Hamasaki, H.
    Yanai, H.
    DIABETES & METABOLISM, 2014, 40 (06) : 481 - 482
  • [49] Efficacy and safety of insulin glulisine and insulin lispro combined with insulin glargine in patients with Type 1 diabetes
    Prager, R
    Dreyer, M
    Robinson, A
    Busch, K
    Penfornis, A
    Souhami, E
    DIABETOLOGIA, 2004, 47 : A301 - A301
  • [50] Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials
    Xiao-Wen Zhang
    Xin-Lin Zhang
    Biao Xu
    Li-Na Kang
    Acta Diabetologica, 2018, 55 : 429 - 441
12345